[ACRX] QoQ Quarter Result on 31-Mar-2017 [#Q1]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
08-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -60.62%
YoY- -41.62%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Revenue 740 1,487 2,659 3,109 6,435 3,366 4,531 -70.02%
PBT -10,588 -13,013 -13,057 -15,551 -9,682 -11,438 -11,092 -3.04%
Tax -703 -3,233 2 -2,704 68 -36 -2,083 -51.42%
NP -9,885 -13,013 -13,059 -15,551 -9,682 -11,402 -11,092 -7.37%
Tax Rate - - - - - - - -
Total Cost 10,625 14,500 15,718 18,660 16,117 14,768 15,623 -22.61%
Ratio Analysis
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
NP Margin -1,335.81 -875.12 -491.12 -500.19 -150.46 -338.74 -244.80 208.99%
Per Share
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
EPS -3.88 -5.61 -5.76 -6.86 -4.27 -5.03 -4.90 -14.37%
EPS Diluted -3.88 -5.61 -5.76 -6.86 -4.27 -5.03 -4.90 -14.37%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.